Molecular Formula: C3232H5032N864O979S41
Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic biologic adumbrated in the analysis of blazon 2 diabetes. It is marketed beneath the brands Eperzan and Tanzeum by GSK (GlaxoSmithKline). It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer alloyed to animal albumin. Albiglutide was accustomed on April 15, 2014 by the FDA.
Albiglutide is an agonist of the GLP-1 (glucagon-like peptide 1) receptor and augments glucose-dependent insulin secretion. Albiglutide aswell slows belly emptying.